Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 22
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Science ; 345(6201): 1130, 2014 Sep 05.
Artigo em Inglês | MEDLINE | ID: mdl-25190789

RESUMO

We appreciate the interest in our paper and the opportunity to clarify theoretical and technical aspects describing the influence of Donnan equilibria on neuronal chloride ion (Cl(-)) distributions.


Assuntos
Encéfalo/metabolismo , Canais de Cloreto/metabolismo , Cloretos/metabolismo , Neurônios/metabolismo , Receptores de GABA-A/metabolismo , Animais
2.
Science ; 343(6171): 670-5, 2014 Feb 07.
Artigo em Inglês | MEDLINE | ID: mdl-24503855

RESUMO

Neuronal intracellular chloride concentration [Cl(-)](i) is an important determinant of γ-aminobutyric acid type A (GABA(A)) receptor (GABA(A)R)-mediated inhibition and cytoplasmic volume regulation. Equilibrative cation-chloride cotransporters (CCCs) move Cl(-) across the membrane, but accumulating evidence suggests factors other than the bulk concentrations of transported ions determine [Cl(-)](i). Measurement of [Cl(-)](i) in murine brain slice preparations expressing the transgenic fluorophore Clomeleon demonstrated that cytoplasmic impermeant anions ([A](i)) and polyanionic extracellular matrix glycoproteins ([A](o)) constrain the local [Cl(-)]. CCC inhibition had modest effects on [Cl(-)](i) and neuronal volume, but substantial changes were produced by alterations of the balance between [A](i) and [A](o). Therefore, CCCs are important elements of Cl(-) homeostasis, but local impermeant anions determine the homeostatic set point for [Cl(-)], and hence, neuronal volume and the polarity of local GABA(A)R signaling.


Assuntos
Encéfalo/metabolismo , Canais de Cloreto/metabolismo , Cloretos/metabolismo , Neurônios/metabolismo , Receptores de GABA-A/metabolismo , Animais , Permeabilidade da Membrana Celular , Polaridade Celular , Citoplasma/metabolismo , Proteínas da Matriz Extracelular/metabolismo , Glicoproteínas/metabolismo , Camundongos , Camundongos Transgênicos , Proteínas Recombinantes de Fusão/genética , Proteínas Recombinantes de Fusão/metabolismo , Transdução de Sinais
3.
Neurobiol Dis ; 38(3): 482-91, 2010 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-20149872

RESUMO

Inflammation has been associated with the two classic lesions in the Alzheimer's (AD) brain, amyloid deposits and neurofibrillary tangles. Recent data suggest that Triflusal, a compound with potent anti-inflammatory effects in the central nervous system in vivo, might delay the conversion from amnestic mild cognitive impairment to a fully established clinical picture of dementia. In the present study, we investigated the effect of Triflusal on brain Abeta accumulation, neuroinflammation, axonal curvature and cognition in an AD transgenic mouse model (Tg2576). Triflusal treatment did not alter the total brain Abeta accumulation but significantly reduced dense-cored plaque load and associated glial cell proliferation, proinflammatory cytokine levels and abnormal axonal curvature, and rescued cognitive deficits in Tg2576 mice. Behavioral benefit was found to involve increased expression of c-fos and BDNF, two of the genes regulated by CREB, as part of the signal transduction cascade underlying the molecular basis of long-term potentiation. These results add preclinical evidence of a potentially beneficial effect of Triflusal in AD.


Assuntos
Doença de Alzheimer/tratamento farmacológico , Doença de Alzheimer/metabolismo , Encéfalo/efeitos dos fármacos , Encéfalo/metabolismo , Fármacos do Sistema Nervoso Central/farmacologia , Salicilatos/farmacologia , Doença de Alzheimer/patologia , Peptídeos beta-Amiloides/genética , Peptídeos beta-Amiloides/metabolismo , Animais , Axônios/efeitos dos fármacos , Axônios/patologia , Encéfalo/patologia , Fator Neurotrófico Derivado do Encéfalo/metabolismo , Transtornos Cognitivos/tratamento farmacológico , Transtornos Cognitivos/metabolismo , Transtornos Cognitivos/patologia , Citocinas/metabolismo , Modelos Animais de Doenças , Humanos , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Transgênicos , Neuroglia/efeitos dos fármacos , Neuroglia/patologia , Placa Amiloide/efeitos dos fármacos , Placa Amiloide/metabolismo , Placa Amiloide/patologia , Proteínas Proto-Oncogênicas c-fos/metabolismo
4.
Phys Med Biol ; 54(20): 6201-16, 2009 Oct 21.
Artigo em Inglês | MEDLINE | ID: mdl-19794239

RESUMO

Amyloid-beta plaques are an Alzheimer's disease biomarker which present unique challenges for near-infrared fluorescence tomography because of size (<50 microm diameter) and distribution. We used high-resolution simulations of fluorescence in a digital Alzheimer's disease mouse model to investigate the optimal fluorophore and imaging parameters for near-infrared fluorescence tomography of amyloid plaques. Fluorescence was simulated for amyloid-targeted probes with emission at 630 and 800 nm, plaque-to-background ratios from 1-1000, amyloid burden from 0-10%, and for transmission and reflection measurement geometries. Fluorophores with high plaque-to-background contrast ratios and 800 nm emission performed significantly better than current amyloid imaging probes. We tested idealized fluorophores in transmission and full-angle tomographic measurement schemes (900 source-detector pairs), with and without anatomical priors. Transmission reconstructions demonstrated strong linear correlation with increasing amyloid burden, but underestimated fluorescence yield and suffered from localization artifacts. Full-angle measurements did not improve upon the transmission reconstruction qualitatively or in semi-quantitative measures of accuracy; anatomical and initial-value priors did improve reconstruction localization and accuracy for both transmission and full-angle schemes. Region-based reconstructions, in which the unknowns were reduced to a few distinct anatomical regions, produced highly accurate yield estimates for cortex, hippocampus and brain regions, even with a reduced number of measurements (144 source-detector pairs).


Assuntos
Doença de Alzheimer/patologia , Peptídeos beta-Amiloides/metabolismo , Espectrometria de Fluorescência/métodos , Espectrofotometria Infravermelho/métodos , Animais , Encéfalo/patologia , Calibragem , Modelos Animais de Doenças , Humanos , Processamento de Imagem Assistida por Computador/métodos , Camundongos , Camundongos Transgênicos , Modelos Estatísticos , Óptica e Fotônica , Reprodutibilidade dos Testes
5.
J Neurochem ; 102(4): 1095-104, 2007 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-17472706

RESUMO

Alzheimer's disease (AD) is characterized by senile plaques and neurodegeneration although the neurotoxic mechanisms have not been completely elucidated. It is clear that both oxidative stress and inflammation play an important role in the illness. The compound curcumin, with a broad spectrum of anti-oxidant, anti-inflammatory, and anti-fibrilogenic activities may represent a promising approach for preventing or treating AD. Curcumin is a small fluorescent compound that binds to amyloid deposits. In the present work we used in vivo multiphoton microscopy (MPM) to demonstrate that curcumin crosses the blood-brain barrier and labels senile plaques and cerebrovascular amyloid angiopathy (CAA) in APPswe/PS1dE9 mice. Moreover, systemic treatment of mice with curcumin for 7 days clears and reduces existing plaques, as monitored with longitudinal imaging, suggesting a potent disaggregation effect. Curcumin also led to a limited, but significant reversal of structural changes in dystrophic dendrites, including abnormal curvature and dystrophy size. Together, these data suggest that curcumin reverses existing amyloid pathology and associated neurotoxicity in a mouse model of AD. This approach could lead to more effective clinical therapies for the prevention of oxidative stress, inflammation and neurotoxicity associated with AD.


Assuntos
Doença de Alzheimer , Curcumina/metabolismo , Curcumina/uso terapêutico , Neuritos/efeitos dos fármacos , Fármacos Neuroprotetores/metabolismo , Fármacos Neuroprotetores/uso terapêutico , Doença de Alzheimer/metabolismo , Doença de Alzheimer/patologia , Doença de Alzheimer/prevenção & controle , Peptídeos beta-Amiloides/metabolismo , Precursor de Proteína beta-Amiloide/genética , Animais , Modelos Animais de Doenças , Ensaio de Imunoadsorção Enzimática , Feminino , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Transgênicos , Neurônios/patologia , Presenilina-1/genética
7.
J Neuropathol Exp Neurol ; 62(2): 137-45, 2003 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-12578223

RESUMO

Postmortem analyses of senile plaques reveal numerous dystrophic processes in their vicinity. We used in vivo multiphoton microscopy of a transgenic model of Alzheimer disease (AD) to simultaneously image senile plaques and nearby neuronal processes. Plaques were labeled by immunofluorescent staining or thioflavine-S and neuronal processes were labeled with a fluorescent dextran conjugate. Imaging of 3-dimensional volumes in the vicinity of plaques revealed subtle changes in neurite geometry in or near diffuse plaques. By contrast, disruptions in neurite morphology, including dystrophic neurites immediately surrounding plaques as well as major alterations in neurite trajectories, were seen in association with thioflavine-S-positive plaques. Nearly half of all labeled processes that came within 50 microm of a thioflavine-S-positive plaque were altered, suggesting a fairly large "halo" of neuropil alterations that extend beyond the discrete border of a thioflavine-S plaque. These results support the hypothesis that compact thioflavine-S-positive plaques disrupt the neuropil in AD.


Assuntos
Doença de Alzheimer/metabolismo , Córtex Cerebral/metabolismo , Neuritos/metabolismo , Placa Amiloide/metabolismo , Tiazóis/metabolismo , Envelhecimento/metabolismo , Envelhecimento/patologia , Doença de Alzheimer/patologia , Doença de Alzheimer/fisiopatologia , Peptídeos beta-Amiloides/metabolismo , Animais , Axônios/metabolismo , Axônios/patologia , Benzotiazóis , Córtex Cerebral/patologia , Córtex Cerebral/fisiopatologia , Dendritos/metabolismo , Dendritos/patologia , Dextranos , Modelos Animais de Doenças , Corantes Fluorescentes , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Transgênicos , Microscopia de Fluorescência por Excitação Multifotônica , Neuritos/patologia , Neurópilo/metabolismo , Neurópilo/patologia , Placa Amiloide/patologia
8.
J Neuropathol Exp Neurol ; 60(3): 274-9, 2001 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-11245211

RESUMO

Transgenic mice overexpressing the human amyloid precursor protein (APPV717F) develop cerebral amyloid angiopathy (CAA) as they age. We have examined the effect of CAA on blood vessels in vivo using multiphoton laser scanning microscopy. We are able to simultaneously detect, in an alive but anesthetized animal, fluorescent angiography of microvessels as well as the presence of amyloid angiopathy in 3-dimensional volumes near the surface of the brain. Analysis revealed dilation of the portions of vessels that were associated with amyloid deposition, even when that amyloid deposition was quite mild. In addition, analysis of the 3-dimensional reconstruction of the relationship between the vasculature and CAA suggest that CAA is initiated close to branch points of vessels. Taken together, these data suggest that CAA has a substantial effect on the physiology of the microvasculature in vivo.


Assuntos
Doença de Alzheimer/patologia , Angiopatia Amiloide Cerebral/patologia , Córtex Cerebral/patologia , Microcirculação/patologia , Microscopia Confocal/métodos , Animais , Modelos Animais de Doenças , Feminino , Processamento de Imagem Assistida por Computador/métodos , Camundongos , Camundongos Transgênicos
10.
J Neurosci ; 21(3): 858-64, 2001 Feb 01.
Artigo em Inglês | MEDLINE | ID: mdl-11157072

RESUMO

In Alzheimer's disease, amyloid-beta peptide aggregates in the extracellular space to form senile plaques. The process of plaque deposition and growth has been modeled on the basis of in vitro experiments in ways that lead to divergent predictions: either a diffusion-limited growth model in which plaques grow by first-order kinetics, or a dynamic model of continual deposition and asymmetrical clearance in which plaques reach a stable size and stop growing but evolve morphologically over time. The models have not been tested in vivo because plaques are too small (by several orders of magnitude) for conventional imaging modalities. We now report in vivo multiphoton laser scanning imaging of thioflavine S-stained senile plaques in the Tg2576 transgenic mouse model of Alzheimer's disease to test these biophysical models and show that there is no detectable change in plaque size over extended periods of time. Qualitatively, geometric features remain unchanged over time in the vast majority of the 349 plaques imaged and re-imaged. Intervals as long as 5 months were obtained. Nonetheless, rare examples of growth or shrinkage of individual plaques do occur, and new plaques appear between imaging sessions. These results indicate that thioflavine S-positive plaques appear and then are stable, supporting a dynamic feedback model of plaque growth.


Assuntos
Doença de Alzheimer/patologia , Microscopia/métodos , Placa Amiloide/metabolismo , Placa Amiloide/patologia , Animais , Benzotiazóis , Modelos Animais de Doenças , Progressão da Doença , Retroalimentação , Corantes Fluorescentes , Processamento de Imagem Assistida por Computador , Masculino , Camundongos , Camundongos Transgênicos , Microscopia/instrumentação , Tiazóis/metabolismo
11.
Proc Natl Acad Sci U S A ; 97(21): 11551-6, 2000 Oct 10.
Artigo em Inglês | MEDLINE | ID: mdl-11016955

RESUMO

The low density lipoprotein receptor-related protein (LRP) is an endocytic receptor that is a member of the low density lipoprotein receptor family. We report that the LRP ligand, activated alpha(2)-macroglobulin (alpha(2)M*), induces robust calcium influx in cultured primary neurons, but not in nonneuronal LRP-containing cells in the same culture. The calcium influx is mediated through N-methyl-d-aspartate receptor channels, which explains the neuron specificity of the response. Microapplication of alpha(2)M* leads to a localized response at the site of application that dissipates rapidly, suggesting that the calcium signal is temporally and spatially discrete. Calcium influx to alpha(2)M* is blocked by the physiological LRP inhibitor, receptor-associated protein. Bivalent antibodies to the extracellular domain of LRP, but not Fab fragments of the same antibody, cause calcium influx, indicating that the response is specific to LRP and may require dimerization of the receptor. Thus, LRP is an endocytic receptor with a novel signaling role.


Assuntos
Sinalização do Cálcio/fisiologia , Endocitose , Neurônios/metabolismo , Receptores Imunológicos/fisiologia , Receptores de N-Metil-D-Aspartato/fisiologia , Animais , Bloqueadores dos Canais de Cálcio/farmacologia , Células Cultivadas , Maleato de Dizocilpina/farmacologia , Antagonistas de Aminoácidos Excitatórios/farmacologia , Proteína-1 Relacionada a Receptor de Lipoproteína de Baixa Densidade , Camundongos , Microscopia Confocal , Receptores de N-Metil-D-Aspartato/antagonistas & inibidores
12.
J Neuroimmunol ; 108(1-2): 227-35, 2000 Aug 01.
Artigo em Inglês | MEDLINE | ID: mdl-10900358

RESUMO

Inflammatory mediators have been implicated in the pathophysiology of neurodegenerative diseases. Here we report the presence of the chemokine receptor CXCR3 and its ligand, IP-10, in normal and Alzheimer's disease (AD) brains. CXCR3 was detected constitutively on neurons and neuronal processes in various cortical and subcortical regions; IP-10 was observed in a subpopulation of astrocytes in normal brain, and was markedly elevated in astrocytes in AD brains. Many IP-10(+) astrocytes were associated with senile plaques and had an apparently coordinated upregulation of MIP-1beta. Moreover, we showed that CXCR3 ligands, IP-10 and Mig, were able to activate ERK1/2 pathway in mouse cortical neurons, suggesting a novel mechanism of neuronal-glial interaction.


Assuntos
Doença de Alzheimer/enzimologia , Astrócitos/metabolismo , Quimiocinas CXC/metabolismo , Peptídeos e Proteínas de Sinalização Intercelular , Proteínas Quinases Ativadas por Mitógeno/metabolismo , Neurônios/metabolismo , Receptores de Quimiocinas/metabolismo , Idoso , Doença de Alzheimer/metabolismo , Doença de Alzheimer/patologia , Animais , Astrócitos/citologia , Astrócitos/enzimologia , Astrócitos/patologia , Células Cultivadas , Córtex Cerebral/citologia , Córtex Cerebral/efeitos dos fármacos , Córtex Cerebral/metabolismo , Córtex Cerebral/patologia , Quimiocina CCL4 , Quimiocina CXCL10 , Quimiocina CXCL9 , Quimiocinas CXC/farmacologia , Ativação Enzimática/efeitos dos fármacos , Feminino , Perfilação da Expressão Gênica , Proteína Glial Fibrilar Ácida/metabolismo , Humanos , Ligantes , Sistema de Sinalização das MAP Quinases/efeitos dos fármacos , Proteínas Inflamatórias de Macrófagos/metabolismo , Camundongos , Neurônios/citologia , Neurônios/enzimologia , Neurônios/patologia , Fosforilação/efeitos dos fármacos , Placa Amiloide/enzimologia , Placa Amiloide/metabolismo , Placa Amiloide/patologia , Receptores CXCR3 , Regulação para Cima
13.
J Neurochem ; 71(4): 1471-81, 1998 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-9751180

RESUMO

N-Methyl-D-aspartate (NMDA) receptors mediate increases in intracellular calcium that can be modulated by protein kinase C (PKC). As PKC modulation of NMDA receptors in neurons is complex, we studied the effects of PKC activation on recombinant NMDA receptor-mediated calcium rises in a nonneuronal mammalian cell line, human embryonic kidney 293 (HEK-293). Phorbol 12-myristate 13-acetate (PMA) pretreatment of HEK-293 cells enhanced or suppressed NMDA receptor-mediated calcium rises based on the NMDA receptor subunit composition. NR2A or NR2B, in combination with NR1(011), conveyed enhancement whereas NR2C and NR2D conveyed suppression. The PKC inhibitor bisindolylmaleimide blocked each of these effects. The region on NR2A that conveyed enhancement localized to a discrete segment of the C terminus distal to the portion of NR2C that is homologous to NR2A. Calcium-45 accumulation, but not intracellular calcium store depletion, matched PMA effects on NMDA receptor-mediated calcium changes, suggesting that these effects were not due to effects on intracellular calcium stores. The suppression of intracellular calcium transients seen with NR2C was eliminated when combined with NR1 splice variants lacking C-terminal cassette 1. Thus, the intracellular calcium effects of PMA were distinguishable based on both the NR1 splice variant and the NR2 subunit type that were expressed. Such differential effects resemble the diversity of PKC effects on NMDA receptors in neurons.


Assuntos
Proteína Quinase C/fisiologia , Receptores de N-Metil-D-Aspartato/metabolismo , Cálcio/metabolismo , Linhagem Celular , Ativação Enzimática/efeitos dos fármacos , Ativação Enzimática/genética , Humanos , Indóis/farmacologia , Rim/citologia , Rim/enzimologia , Rim/metabolismo , Maleimidas/farmacologia , Mutagênese Sítio-Dirigida , Proteína Quinase C/antagonistas & inibidores , Proteína Quinase C/metabolismo , Receptores de N-Metil-D-Aspartato/efeitos dos fármacos , Receptores de N-Metil-D-Aspartato/genética , Acetato de Tetradecanoilforbol/farmacologia , Tapsigargina/farmacologia , Transfecção
14.
J Biol Chem ; 272(1): 647-56, 1997 Jan 03.
Artigo em Inglês | MEDLINE | ID: mdl-8995308

RESUMO

N-methyl-D-aspartate (NMDA) receptors can mediate cell death in neurons and in non-neuronal cells that express recombinant NMDA receptors. In neurons, increases in intracellular calcium correlate with NMDA receptor-mediated death, supporting a key role for loss of cellular calcium homeostasis in excitotoxic cell death. In the present study, free intracellular calcium concentrations were examined in response to activation of recombinant NMDA receptors expressed in human embryonic kidney 293 cells. Intracellular calcium was measured in transfected cell populations by cotransfection with the calcium-sensitive, bioluminescent protein aequorin and by single cell imaging with the fluorescent calcium indicator fluo-3. Agonist application to NR1/2A or NR1/2B-transfected cells elicited robust rises in intracellular calcium. NR1/2A responses were inhibited by the noncompetitive antagonists MK-801 and dextromethorphan and were dependent on extracellular calcium but not on intracellular calcium stores. In contrast, no detectable intracellular calcium responses were observed in NR1/2C-transfected cells. These findings indicate that NMDA receptors in the absence of other neuron-specific factors can mediate increases in intracellular calcium with subunit specificity and extracellular calcium dependence.


Assuntos
Cálcio/metabolismo , Receptores de N-Metil-D-Aspartato/fisiologia , Linhagem Celular , Maleato de Dizocilpina/farmacologia , Glutamatos/farmacologia , Humanos , Receptores de N-Metil-D-Aspartato/antagonistas & inibidores , Receptores de N-Metil-D-Aspartato/classificação , Proteínas Recombinantes , Serotonina/farmacologia , Transdução de Sinais , Transfecção
15.
Neuron ; 14(1): 19-28, 1995 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-7826636

RESUMO

In lamprey spinal cord, intracellular calcium ([Ca2+]i) plays a key role in mechanisms regulating neuronal activity in the segmental network for locomotion. In this report, measurements of [Ca2+]i with fluo-3 in various regions of motoneurons in the intact spinal cord were obtained on a high speed confocal microscope following electrical stimulation. Likewise, rhythmic calcium fluctuations within dendrites and axons were seen during "fictive swimming" and were directly correlated with electrical activity. Antidromic stimulation of motoneuron axons induced large calcium transients and revealed spatially restricted "hot spots," both of which required external calcium and were blocked by nickel, but not by known calcium channel antagonists. These results suggest that lamprey spinal cord axons may possess a pharmacologically novel class of calcium channel.


Assuntos
Cálcio/metabolismo , Microscopia Confocal , Microscopia de Vídeo , Neurônios Motores/metabolismo , Compostos de Anilina , Animais , Axônios/metabolismo , Cálcio/farmacologia , Bloqueadores dos Canais de Cálcio/farmacologia , Dendritos/metabolismo , Estimulação Elétrica , Potenciais Evocados , Corantes Fluorescentes , Lampreias , Neurônios Motores/ultraestrutura , Níquel/farmacologia , Medula Espinal/citologia , Natação , Sinapses/fisiologia , Xantenos
16.
Neuron ; 13(4): 837-48, 1994 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-7946332

RESUMO

Drosophila phototransduction is a phosphoinositide-mediated and Ca(2+)-regulated signaling cascade ideal for the dissection of feedback regulatory mechanisms. To study the roles of intracellular Ca2+ ([Ca2+]i) in this process, we developed novel techniques for the measurement of [Ca2+]i in intact photoreceptors. We genetically engineered flies that express a UV-specific rhodopsin in place of the normal rhodopsin, so that long wavelength light can be used to image [Ca2+]i changes while minimally exciting the photoreceptor cells. We show that activation with UV generates [Ca2+]i increases that are spatially localized to the rhabdomeres and that are entirely dependent on the influx of extracellular Ca2+. Application of intracellular Ca2+ chelators of varying affinities demonstrates that the Ca2+ influx initially generates a large-amplitude transient that is crucial for negative regulation. Internal Ca2+ stores were revealed by discharging them with thapsigargin. But, in contrast to proposals that IP3-sensitive stores mediate phototransduction, thapsigargin does not mimic or acutely interfere with photoexcitation. Finally, we identify a photoreceptor-specific PKC as essential for normal kinetics of [Ca2+]i recovery.


Assuntos
Cálcio/metabolismo , Citosol/metabolismo , Drosophila/metabolismo , Células Fotorreceptoras de Invertebrados/fisiologia , Animais , Drosophila/genética , Condutividade Elétrica , Espaço Extracelular/metabolismo , Engenharia Genética , Cinética , Microscopia Confocal , Células Fotorreceptoras de Invertebrados/efeitos da radiação , Células Fotorreceptoras de Invertebrados/ultraestrutura , Proteína Quinase C/metabolismo , Rodopsina/genética , Rodopsina/efeitos da radiação , Terpenos/farmacologia , Tapsigargina , Raios Ultravioleta
17.
J Bone Miner Res ; 9(9): 1407-17, 1994 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-7817824

RESUMO

We previously demonstrated that the [Ca2+]i response to PTH is heterogeneous in single UMR-106-01 osteogenic sarcoma cells. To verify whether response heterogeneity is a universal feature of PTH signal transduction, cAMP production was monitored in monolayer cultures of UMR-106-01 cells and human trabecular bone osteoblasts (HOB) using the cAMP-sensitive fluorescent indicator FlCRhR. FlCRhR was microinjected into single cells, and the 500-530/> 560 nm fluorescence ratio was monitored by confocal laserscanning video imaging as a measure of cAMP concentration ([cAMP]). Virtually all UMR-106-01 cells exposed to bovine PTH(1-34) (10(-7) M) exhibited an increase in intracellular [cAMP], with an average fluorescence ratio change of 145 +/- 17% of baseline (n = 15), corresponding to nearly maximal dissociation of protein kinase A. In the continued presence of the hormone (10(-7) M), [cAMP] remained elevated for at least 30 minutes. This effect was accompanied by a slow translocation of the fluorescein-labeled catalytic subunit of protein kinase A from the cytoplasm to the nucleus. In contrast, PTH(1-34) caused no detectable increase in [cAMP] in HOB cells, although PGE2 (3 x 10(-6) M) stimulation was able to increase the FlCRhR ratio (154 +/- 27%, n = 10). The truncated fragment PTH(2-34) was only 67% as potent at PTH(1-34), but deletion of the first two amino acids at the N terminus abolished the hormone's ability to stimulate cAMP production in UMR-106-01 cells. Brief exposure to 10(-7) M of either PTH(3-34) or PTH(7-34) did not affect the amplitude of the fluorescence ratio change induced by equimolar doses of PTH(1-34). Thus, in osteoblast-like cells stimulated with PTH, the [cAMP] response is much more homogeneous from cell to cell than the [Ca2+]i response.


Assuntos
AMP Cíclico/metabolismo , Osteoblastos/efeitos dos fármacos , Hormônio Paratireóideo/farmacologia , Fragmentos de Peptídeos/farmacologia , Animais , Neoplasias Ósseas/patologia , Cálcio/metabolismo , Proteínas Quinases Dependentes de AMP Cíclico/metabolismo , Corantes Fluorescentes/administração & dosagem , Corantes Fluorescentes/química , Humanos , Processamento de Imagem Assistida por Computador , Microinjeções , Microscopia Confocal , Microscopia de Fluorescência , Osteossarcoma/patologia , Ratos , Transdução de Sinais/efeitos dos fármacos , Teriparatida , Células Tumorais Cultivadas
18.
Trends Cell Biol ; 3(7): 242-5, 1993 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-14731760
19.
Science ; 260(5105): 222-6, 1993 Apr 09.
Artigo em Inglês | MEDLINE | ID: mdl-7682336

RESUMO

Cyclic adenosine monophosphate (cAMP)-dependent protein kinase, labeled with fluorescein and rhodamine on the catalytic and regulatory subunits, respectively, was injected into Aplysia sensory neurons either in culture or in intact cell clusters. Energy transfer between the subunits, a measure of cytosolic cAMP concentration ([cAMP]), and compartmentation of the dissociated subunits were monitored by confocal fluorescence microscopy. Bath application of serotonin produced a much greater elevation of [cAMP] in the processes than in the central bodies of the neurons. The resulting gradients must drive a sizable centripetal flux of cAMP because direct microinjection of cAMP showed that it diffused readily. Perinuclear increases in [cAMP] slowly caused the translocation of the freed catalytic subunit into the nucleus to an extent proportional to the percentage of its dissociation from the regulatory subunit.


Assuntos
AMP Cíclico/metabolismo , Neurônios Aferentes/metabolismo , Proteínas Quinases/metabolismo , 1-Metil-3-Isobutilxantina/farmacologia , Animais , Aplysia , Compartimento Celular , Núcleo Celular/enzimologia , Núcleo Celular/metabolismo , Células Cultivadas , Citoplasma/enzimologia , Citoplasma/metabolismo , Difusão , Fluoresceína , Fluoresceínas , Microinjeções , Neurônios Aferentes/efeitos dos fármacos , Neurônios Aferentes/enzimologia , Rodaminas , Serotonina/farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...